{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T17:14:31Z","timestamp":1791220471277,"version":"4.1.0"},"reference-count":17,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1097\/cmr.0b013e3283610586","type":"journal-article","created":{"date-parts":[[2013,3,30]],"date-time":"2013-03-30T13:45:11Z","timestamp":1364651111000},"page":"196-198","source":"Crossref","is-referenced-by-count":37,"title":["Treatment of metastatic uveal melanoma with intravenous fotemustine"],"prefix":"10.1097","volume":"23","author":[{"given":"Francesco","family":"Spagnolo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Grosso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginia","family":"Picasso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Tornari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianna","family":"Pesce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Queirolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-4-20210129","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1097\/01.iio.0000195852.08453.de","article-title":"Metastatic uveal melanoma therapy: current options.","volume":"46","author":"Hu","year":"2006","journal-title":"Int Ophthalmol Clin"},{"key":"R2-4-20210129","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1586\/14737140.6.4.493","article-title":"Treatment of primary intraocular melanoma.","volume":"6","author":"Damato","year":"2006","journal-title":"Expert Rev Anticancer Ther"},{"key":"R3-4-20210129","doi-asserted-by":"crossref","first-page":"4651","DOI":"10.1167\/iovs.03-0538","article-title":"Very long-term prognosis of patients with malignant uveal melanoma.","volume":"44","author":"Kujala","year":"2003","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R6-4-20210129","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ohc.2004.07.003","article-title":"Metastatic uveal melanoma.","volume":"18","author":"Singh","year":"2005","journal-title":"Ophthalmol Clin North Am"},{"key":"R7-4-20210129","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1097\/01.iio.0000195852.08453.de","article-title":"Metastatic uveal melanoma therapy: current options.","volume":"46","author":"Bedikian","year":"2006","journal-title":"Int Ophthalmol Clin"},{"key":"R10-4-20210129","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/S0959-8049(03)00132-1","article-title":"Bleomicin, vincristine, lomustine and dacarbazine (BOLD) in combination with recombinant interferon alpha-2b for metastatic uveal melanoma.","volume":"39","author":"Kivela","year":"2003","journal-title":"Eur J Cancer"},{"key":"R11-4-20210129","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1097\/00008390-200306000-00013","article-title":"Phase II evaluation of temozolomide in metastatic choroidal melanoma.","volume":"13","author":"Bedikian","year":"2003","journal-title":"Melanoma Res"},{"key":"R12-4-20210129","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1097\/00008390-200510000-00014","article-title":"A two-cohort phase II clinical trial of gemcitabine plus treosulfan in patients with metastatic uveal melanoma.","volume":"15","author":"Schmittel","year":"2005","journal-title":"Melanoma Res"},{"key":"R13-4-20210129","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1093\/annonc\/mdl309","article-title":"Phase II trial of cisplatin, gemcitabine plus treosulfan versus treosulfan alone in patients with metastatic uveal melanoma.","volume":"17","author":"Schmittel","year":"2006","journal-title":"Ann Oncol"},{"key":"R14-4-20210129","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1097\/01.cmr.0000205017.38859.07","article-title":"A prospective single arm phase II study of dacarbazine and treosulfan as first line therapy in metastatic uveal melanoma.","volume":"16","author":"ONeill","year":"2006","journal-title":"Melanoma Res"},{"key":"R15-4-20210129","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1097\/CMR.0b013e3283403ce9","article-title":"Phase II open-label study of weekly docosahexaenoic acid-paclitaxel in patients with metastatic uveal melanoma.","volume":"20","author":"Homsi","year":"2010","journal-title":"Melanoma Res"},{"key":"R16-4-20210129","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1097\/CMR.0b013e328311aaa1","article-title":"A pilot study with vincristine sulfate liposome infusion in patients with metastatic melanoma.","volume":"18","author":"Bedikian","year":"2008","journal-title":"Melanoma Res"},{"key":"R17-4-20210129","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.ctrv.2012.01.002","article-title":"Uveal melanoma.","volume":"38","author":"Spagnolo","year":"2012","journal-title":"Cancer Treat Rev"},{"key":"R19-4-20210129","doi-asserted-by":"crossref","first-page":"629","DOI":"10.2217\/14796694.4.5.629","article-title":"Emerging insights into the molecular pathogenesis of uveal melanoma.","volume":"4","author":"Landreville","year":"2008","journal-title":"Future Oncol"},{"key":"R20-4-20210129","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1158\/1078-0432.CCR-08-2243","article-title":"Overexpression of the KITSCF in uveal melanoma does not translate into clinical efficacy of imatinib mesylate.","volume":"15","author":"Hofmann","year":"2009","journal-title":"Clin Cancer Res"},{"key":"R22-4-20210129","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/j.1755-148X.2010.00821.x","article-title":"Uveal melanoma and GNA11 mutations: a new piece added to the puzzle.","volume":"24","author":"Besaratinia","year":"2011","journal-title":"Pigment Cell Melanoma Res"},{"key":"R25-4-20210129","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/cncr.11872","article-title":"Prolonged survival after complete resection of metastases from intraocular melanoma.","volume":"100","author":"Hsueh","year":"2004","journal-title":"Cancer"}],"container-title":["Melanoma Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CMR.0b013e3283610586","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,24]],"date-time":"2021-05-24T20:24:22Z","timestamp":1621887862000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00008390-201306000-00004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6]]},"references-count":17,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/cmr.0b013e3283610586","relation":{},"ISSN":["0960-8931"],"issn-type":[{"value":"0960-8931","type":"print"}],"subject":[],"published":{"date-parts":[[2013,6]]}}}